There is new insight into the debate over the use of oral contrast in the ED setting when evaluating patients with acute abdominal pain (AAP). A 2023 study from the University of Michigan saw a 30%...

Early in spring of 2022, GE shutdown its iohexol manufacturing facility in Shanghai to comply with China’s zero-covid policy. GE was unprepared for this sudden halt of production and flew dye to...

If the COVID-19 pandemic taught us anything, it revealed how fragile our supply chain systems really are. As of this writing, the US is experiencing a critical shortage of the contrast medium Iohexol.

Patients who have had an abdominal CT scan say that drinking the contrast before the procedure can be the worst part of the whole process because of the texture and/or flavor.

Hospitals and imaging centers are looking for ways to limit exposure and potential transmission of the coronavirus between their patients and medical staff. One way is to limit their interaction with...

Every hospital has its own set of protocols to address the needs of their patient population. When it comes to diagnostic CT, drinking protocols for oral contrast can vary from facility to facility.

Happy customers often turn into repeat customers. More importantly, they tell their friends about their positive experience. This is true for any business, including medical imaging.

There has been much debate in the last few years regarding the use of positive oral contrast for patients with acute abdominal pain in the ED setting.

Two of the exams used in the diagnosis of abdominal diseases include a routine CAT-Scan (CT) of the abdomen and pelvis, and small bowel enterography which can be performed in either CT or MRI.